Cognition Therapeutics Inc SEC filings CGTX
Cognition Therapeutics Inc has 303 filings in SEC EDGAR's recent list, going back to Jan 29, 2009. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, listing notice). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations, Listing notice
|
Nov 5, 2026 | Nov 3, 2026 |
| 8-K |
Current report
Other events
|
Oct 22, 2026 | Oct 22, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Other events
|
Jun 24, 2026 | Jun 24, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 4, 2026 | Jun 4, 2026 |
| 8-K |
Current report
Other events
|
May 21, 2026 | May 21, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 26, 2026 | Mar 26, 2026 |
| 8-K |
Current report
Other events
|
Mar 2, 2026 | Mar 2, 2026 |
| 8-K |
Current report
Other events
|
Jan 27, 2026 | Jan 27, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Dec 18, 2025 | Dec 16, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Other events
|
Sep 15, 2025 | Sep 15, 2025 |
| 8-K |
Current report
Material agreement
|
Aug 28, 2025 | Aug 27, 2025 |
| 8-K |
Current report
Other events
|
Aug 26, 2025 | Aug 26, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 20, 2025 | Jun 18, 2025 |
| 8-K |
Current report
Other events
|
Jun 3, 2025 | Jun 3, 2025 |
| 8-K |
Current report
Other events
|
Jun 2, 2025 | Jun 2, 2025 |
| 8-K |
Current report
Other events
|
May 8, 2025 | May 8, 2025 |
| 8-K |
Current report
Results of operations
|
May 7, 2025 | May 7, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 20, 2025 | Mar 20, 2025 |
| 8-K |
Current report
Other events
|
Mar 12, 2025 | Mar 12, 2025 |
| 8-K |
Current report
Other events
|
Feb 26, 2025 | Feb 26, 2025 |
| 8-K |
Current report
Other events
|
Jan 28, 2025 | Jan 28, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Other events
|
Dec 18, 2024 | Dec 18, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 1, 2024 | Oct 1, 2024 |
| 8-K |
Current report
Listing notice
|
Sep 13, 2024 | Sep 12, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 28, 2024 | Aug 28, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Other events
|
Jul 29, 2024 | Jul 29, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 7, 2024 | Jun 7, 2024 |
| 8-K |
Current report
Results of operations
|
May 7, 2024 | May 7, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 26, 2024 | Mar 26, 2024 |
| 8-K |
Current report
Material agreement
|
Mar 13, 2024 | Mar 11, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2024 | Mar 11, 2024 |
| 8-K |
Current report
Officer or director change
|
Feb 20, 2024 | Feb 15, 2024 |
| 8-K |
Current report
Other events
|
Jan 4, 2024 | Jan 4, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Other events
|
Sep 12, 2023 | Sep 12, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 24, 2023 | Aug 24, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Other events
|
Jun 28, 2023 | Jun 28, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2023 | Jun 9, 2023 |
| 8-K |
Current report
Results of operations
|
May 4, 2023 | May 4, 2023 |
| 8-K |
Current report
Officer or director change
|
May 1, 2023 | May 1, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 19, 2023 | Apr 19, 2023 |
| 8-K |
Current report
Other events
|
Mar 28, 2023 | Mar 28, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 23, 2023 | Mar 23, 2023 |
| 8-K |
Current report
Other events
|
Mar 15, 2023 | Mar 15, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Material agreement, Results of operations
|
Mar 10, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Other events
|
Feb 22, 2023 | Feb 22, 2023 |
| 8-K |
Current report
Other events
|
Feb 13, 2023 | Jan 27, 2023 |
| 8-K |
Current report
Material agreement
|
Dec 23, 2022 | Dec 23, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 16, 2022 | Nov 16, 2022 |
| 8-K |
Current report
Material agreement, Results of operations, Other events
|
Nov 14, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 29, 2022 | Aug 29, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 9, 2022 | Aug 9, 2022 |
| 8-K |
Current report
Officer or director change
|
Jul 27, 2022 | Jul 21, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 16, 2022 | Jun 16, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2022 | Jun 10, 2022 |
| 8-K |
Current report
Results of operations
|
May 11, 2022 | May 11, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2022 | Mar 30, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 15, 2022 | Mar 15, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 10, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 18, 2021 | Nov 18, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 12, 2021 | Nov 10, 2021 |
| 8-K |
Current report
Officer or director change
|
Nov 3, 2021 | Oct 29, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Oct 14, 2021 | Oct 13, 2021 |
Showing 73 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CGTX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Purchase, NY
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1455365
- Former names
- COGNITION THERAPUTICS INC (until Dec 28, 2010)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.